Should we screen for breast cancer?

BMJ (Online)

Volumn 341, Issue 7766, 2010, Pages 233-235

  McPherson, Klim ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; EARLY INTERVENTION; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; MORTALITY; MULTIMODALITY CANCER THERAPY; OBESITY; OUTCOME ASSESSMENT; OVERDIAGNOSIS; PARTIAL MASTECTOMY; PATIENT DECISION MAKING; PHYSICAL EXAMINATION; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; VALIDITY;

EID: 77955112781     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. US Preventive Services Task Force. Screening for breast cancer: recommendation statement. Ann Int Med 2009;151:716-26.
2. Electronic responses. Screening for breast cancer: recommendation statement Ann Int Med 2009. www.annals.org/content/151/10/716.full/reply.
3. Kamerow D. Mammograms, poor communication, politics. BMJ 2009:339:b5175.
4. Nelson HD, Tyne K, Nalk A, Bougatsos K, Chan BK, Humphrey L. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 2009;151:727-37.
5. Olsen O, Gotzshe PC. Cochrane review on screening for breast cancer with mammography. Lancet 2002;358:1340-2.
6. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009;4:CD001877.
7. Gotzsche P, Hartling OJ, Nielsen M, Brodersen J, Jørgensen KJ. Breast screening the facts - or maybe not. BMJ 2009;338:b86.
8. Cancer Research UK. Breast cancer - the facts. http://info. cancerresearchuk.org/cancerstats/types/breast.
9. Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, et al. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res 2008;10:R26.
10. Flanders J. Reality of ductal carcinoma in situ. BMJ 2009;338:b958.
11. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-68.
12. Banks E. Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review. J Med Screen 2001;8:29-34.
13. Moser K, Patnick J, Beral V. Inequalities in the reported use of breast and cervical screening in Great Britain: analysis of cross sectional study. BMJ 2009;338:b2025.
14. Jorgensen KJ, Gotzshe P. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.
15. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006;332:689-92.
16. Welch HG. Overdiagnosis and mammography screening. BMJ 2009;339:b1425.
17. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening from a randomized trial and from the breast screening programme in England. J Med Screen 2010;17:25-30.
18. Electronic responses to Jørgensen KJ et al. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010. www.bmj.com/cgi/eletters/340/mar23-1/c1241.
19. Moss S. Overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005;7:230-4. (Pubitemid 41387438)
20. Miller AB, To T, Baines C, Wall C. Canadian national breast screening study-2: 13-year results of a randomized trail in women aged 50-59. J Can Canc Inst 2000;92:1490-9.